CSF sTREM2: Marking the tipping point between preclinical AD and dementia?

Authors

Suzanne E. Schindler, Washington University School of Medicine in St. Louis
David M. Holtzman, Washington University School of Medicine in St. Louis

Journal

EMBO Molecular Medicine

Publication Date

2016

Volume

8

Issue

5

Inclusive Pages

437-438

Document Type

Open Access Publication

DOI

10.15252/emmm.201606245

Rights and Permissions

Schindler SE, Holtzman DM (2016) CSF sTREM2: Marking the tipping point between preclinical AD and dementia? EMBO Molecular Medicine, 8(5): 437-438. DOI:10.15252/emmm.201606245 Copyright 2016 The Authors. Published under the terms of the CC BY 4.0 license

Recommended Citation

Schindler, Suzanne E. and Holtzman, David M., "CSF sTREM2: Marking the tipping point between preclinical AD and dementia?." EMBO Molecular Medicine. 8, 5. 437-438. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/6623